Fw: nirmal metro issue 146 yr 7

[manish publication]

THE ECONOMIC REVOLUTION, ALWAYS TRUE
OUR WRITERS ARE OUR PROUD
Our writer col. Ajay, Astromoney guru always right
He wrote  
   Zig-zag move in Gold expected

IPO Review by dilip davda
1.Anand Rayons BSE SME IPO review (Avoid)



The textile segment is not fancied by investors in the given scenario. The issue is priced very aggressively. Guiness group has a topsy-turvy background. Considering all these facts, it is better to skip this issue.

2.Parshva Enterprises BSE SME IPO review (Avoid)



PEL has just 21 months working records. The issue is priced very aggressively. Merchant Banker has an average track record. PEL operates in a highly competitive segment. Its current issue size may take a longer time for migration to the main board. Considering all these aspects, investors may skip this issue.
3.Sudarshan Pharma NSE SME IPO Famous IPO analyst and this magazine's writer Shree Dilip Davda informs that Pharma industries is a highly regulated sector. Pharma shares are not chosen by investors. Recently listed pharma companies have disappointed the investors through their weak performance. If this shares are considered keeping in mind the 2019 earning then these share are available at 41 pe ratio. Due to high rates there is no Loss in leaving or not applying for this shares.
4 Mira And BSE SME I P OThis shares have given attractive long term returns according to maiden ipo rate and has shown improvement in top and bottom lines. However  this ipo  deserves more rate than its market price rs. 208.65. Loss in market to investors can't be ignored. So whoever investors have more cash and is ready to take risk can sell by taking risk.



For detail log in  www.theeconomicrevolution.in